Dr. Gaston is a physician-scientist who has been continuously funded by NIH for over 20 years.
He is particularly focused on translating basic science discoveries from his group into therapies and diagnostic tools relevant to respiratory medicine. Specific projects include new therapies for severe asthma and other obstructive lung diseases; and for opioid-induced respiratory depression and other causes of apnea.
Recent discoveries also include the role of the voltage-gated potassium channel in stereoselective S-nitrosocysteine signaling.
